The Human Medicines (Amendment) Regulations 2016

Amendment of Schedule 17 (exemption for sale, supply or administration by certain persons)

This section has no associated Explanatory Memorandum

16.—(1) Schedule 17 is amended as follows.

(2) In the table in Part 1(1) (exemption from restrictions on sale and supply of prescription only medicines), after item 12 in the table insert—

“13 Registered orthoptists.

13 The following prescription only medicines–

(a) Atropine,

(b) Cyclopentolate,

(c) Tropicamide,

(d) Lidocaine with fluorescein,

(e) Oxybuprocaine,

(f) Proxymetacaine,

(g) Tetracaine,

(h) Chloramphenicol,

(i) Fusidic acid.

13 The sale or supply shall be only in the course of their professional practice.”

(3) In the table in Part 2(2) (exemption from the restriction on supply of prescription only medicines), after item 11 in the table insert—

“12 Registered midwives.

12 Prescription only medicines for parenteral administration that contain–

(a) Diamorphine,

(b) Morphine,

(c) Pethidine hydrochloride.

12 The supply shall be only in the course of their professional practice.”

(4) In the table in Part 4(3) (exemption for certain persons who sell or supply certain medicinal products), after item 12 in the table insert—

“13 Registered orthoptists.

13 All medicinal products on a general sale list, all pharmacy medicines and the following prescription only medicines–

(a) Atropine,

(b) Cyclopentolate,

(c) Tropicamide,

(d) Lidocaine with fluorescein,

(e) Oxybuprocaine,

(f) Proxymetacaine,

(g) Tetracaine,

(h) Chloramphenicol,

(i) Fusidic acid.

13 The sale or supply shall be only in the course of their professional practice.”
(1)

Part 1 was amended by S.I. 2014/1878.

(2)

Part 2 was amended by S.I. 2014/1878 and 2015/1503.

(3)

Part 4 was amended by S.I. 2013/2593.